Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 13/11/2026			5-day change	1st Jan Change
15.31 ^MXN	-2.11%		-3.95%	-14.42%

10-22	Genomma Lab Internacional, S.A.B. de C.V., Q3 2026 Earnings Call, Oct 22, 2026
10-21	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	14,903	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-14.71%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	19,093	18,568	18,135
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-14.16%	-2.75%	-2.33%
P/E	14.9x	12x	13.1x	11.7x	11.1x	7.87x	7.75x	6.94x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	1.06x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.4x	5.14x	0.6x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.84x	0.8x	0.75x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	1.07x	0.99x	0.91x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.7x	4.34x	3.98x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	5.15x	4.78x	4.37x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	13.3x	9.32x	8.44x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	7.54%	10.7%	11.8%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8003	1.071	1.441
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.23%	7%	9.41%
EPS ²	1.44	1.41	1.08	2.14	1.61	1.946	1.975	2.206
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	41.1%	54.2%	65.3%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	17,805	18,740	19,945
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,061	4,279	4,559
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,705	3,886	4,146
Net income ¹	1,451	1,397	1,031	2,137	1,607	1,951	2,058	2,285
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,190	3,666	3,233
Reference price ²	21.48	16.94	14.16	25.13	17.89	15.31	15.31	15.31
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	973,386	-	-
Announcement Date	23/02/22	22/02/23	21/02/24	26/02/25	25/02/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	7.87x	1.07x	4.7x	5.23%	803M
ELI LILLY AND COMPANY	42.25x	14.3x	30.31x	0.47%	1,286B
JOHNSON & JOHNSON	41.82x	7.01x	19.73x	1.87%	688B
ABBVIE INC.	37.62x	8.63x	17.81x	2.34%	521B
ROCHE HOLDING AG	21.75x	5.27x	13.2x	2.48%	386B
MERCK & CO., INC.	104.88x	5.98x	25.49x	2.3%	364B
NOVARTIS AG	24x	5.82x	14.17x	2.73%	302B
ASTRAZENECA PLC	24.25x	4.85x	13.63x	1.8%	287B
AMGEN INC.	24.04x	7.38x	13.56x	2.17%	252B
GILEAD SCIENCES, INC.	-39.49x	7.32x	46.07x	1.96%	208B
Average	28.90x	6.76x	19.87x	2.33%	430B
Weighted average by Cap.	37.56x	8.95x	22.68x	1.68%